(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Kiefer Sutherland arrested after allegedly assaulting a ride-share driver in L.A. - 2Tracking down the Right Equilibrium: Charges versus Personal Costs in Senior Protection.
- 3Study shows no clear link between low-fat dairy and dementia risk
- 4Collection of 7,000-year-old ostrich eggs discovered under sand dunes in southern Israel
- 5Instructions to Discuss Successfully with Your Auto Collision Lawyer
- Instructions to Expand Your Smash 1500's Presentation: Tips and Deceives
- Saucony's $125 'Comfy, Stylish' Sneakers Are Now $55
- Kremlin: Russian troops conquer Pokrovsk after year of intense combat
- A definitive Handbook for Securities exchange Money management
- Brazil's agricultural research agency gets cannabis research greenlight
- Ford Is Using a Chinese-Built Van to Fight Europe’s EV Price War
- Holden Commodore Turbo BT1 Police Interceptor Offered for Sale in Australia
- As nations push for more ambition at climate talks, chairman says they may get it
- 8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
